Login to Your Account


Jack-of-all-trades antibodies make for good HIV vaccine

By Anette Breindl
Science Editor

Friday, March 21, 2014
A vaccine that provided modest protection from contracting HIV in the RV144 “Thai” trial appears to have done so by inducing a broad, “polyfunctional” antibody response, rather than high titers of neutralizing antibodies that are the goal of vaccine development efforts. Galit Alter told BioWorld Todaythat the results “force the field to look at other options. . . . Studying binding titers and neutralization is not enough.” Alter is at the Ragon Institute and the corresponding author of one of two papers reporting the findings.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription